|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00383 TIANAN MEDICARE
Nominal 
0.990 +0.010 (+1.020%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 1,627,199 | 3.721% | 1,568,824 | 1,437,863 | 1,463,495 | 1,194,148 |
| Cost of Sales | (1,290,979) | 0.977% | (1,278,490) | (1,172,307) | (1,196,037) | (973,416) |
| Gross Profit | 336,220 | 15.805% | 290,334 | 265,556 | 267,458 | 220,732 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (34,043) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 57,004 | 39.699% | 40,805 | (117,169) | (110,468) | (96,562) | |
| Taxation | (15,028) | 0.778% | (14,912) | (1,976) | (16,802) | (8,577) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (13,203) | 17.726% | (11,215) | (4,429) | (10,026) | (6,789) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 28,773 | 96.028% | 14,678 | (123,574) | (137,296) | (111,928) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (3,383) | -- | 23,341 | 55,057 | 56,825 | 45,846 |
| Depreciation & Amortisation | 97,307 | 4.837% | 92,817 | 104,693 | 104,529 | 116,431 |
| Directors' Emoluments | 4,766 | -4.527% | 4,992 | 3,290 | 4,188 | 4,885 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 2.650 | 66.667% | 1.590 | -16.940 | -18.752 | -15.290 |
| DPS (cts) | 2.000 | -- | 1.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 75.472% | -- | 62.893% | -- | -- | -- |
| Cash flow per share ($) | 0.098 | -- | 0.385 | 0.097 | 0.303 | (0.001) |
| NBV per share ($) | 1.675 | -- | 1.665 | 2.124 | 2.323 | 2.438465 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 11,979 |
| %Change | -44.693% |
| EPS / (LPS) | HKD 0.011 |
| NBV Per Share ($) | HKD 1.679 |